Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Zokinvy, lonafarnib, Progeria;Laminopathies, Date of authorisation: 18/07/2022, Revision: 2, Status: Authorised
TO: